Hyperfine, Inc. (HYPR) Stock

Hyperfine, Inc. (HYPR) is a Healthcare stock trading at $0.90 (as of 2026-08-20), with a market capitalization of $87.85M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Understand Hyperfine, Inc.: how it makes money

Hyperfine makes portable MRI and related imaging and monitoring systems, led by the Swoop Portable MR imaging system, and it monetizes this through a combination of hardware sales and software services.

The profit model appears to hinge on scaling commercial placement of Swoop systems (installed base), and then leveraging that installed base through ongoing software services and continued imaging activity, as suggested by the focus on systems sold and images collected.

Business quality (Weak): Clear product and operating metrics are provided (commercial systems and imaging activity), but no official segment revenue split is included in the provided facts.

Bull case

  • Commercial adoption metrics are in the data: The provided operating metrics show commercial Swoop systems installed at 10, with systems placed at 13 and commercial Swoop systems sold at 8.
  • Indication of in-use imaging activity: The company reports 150,000 images collected, which can signal ongoing system usage as commercial adoption progresses.
  • Next-generation mix is measurable: Next generation Swoop systems represent 63% of commercial Swoop systems sold in the provided metrics.

Bear case

  • Profitability is currently weak: The latest provided financials show an operating margin of -219.3%.
  • Revenue and revenue breakdown are not usable from the provided facts: The provided financials list revenue as 0.0B and do not provide an official device versus service revenue split, which limits confidence in interpreting the revenue engine.
Valuation — source: SEC EDGAR (first-party)
Price$0.90
Market Cap$87.85M
Price / Book2.56
Price / Sales7.22
FCF Yield-69.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$13.56M
Net Margin-262.3%
Revenue Growth (YoY)5.2%
EPS Growth (YoY)-23.2%
FCF Growth (YoY)-25.6%
Financial Health — source: SEC EDGAR
Altman Z-Score-6.38 (distress)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)32.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD CAPITAL MANAGEMENT LLC ($3.73M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOMaria Degois-Sainz
Employees111
CountryUS
IPO Date2021-01-28

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Stereotaxis, Inc. (STXS)
  • FONAR Corporation (FONR)
  • Vivani Medical, Inc. (VANI)
  • electroCore, Inc. (ECOR)
  • Streamex Corp. (STEX)
  • Outset Medical, Inc. (OM)
  • NeurAxis, Inc. (NRXS)
  • Precision Optics Corporation, Inc. (POCI)
HYPR earnings history · HYPR institutional & insider holders · HYPR KPIs & operating metrics · HYPR financials · HYPR investor presentations & press releases · HYPR SEC filings · HYPR peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.